NasdaqGM:ARDXBiotechs
Ardelyx (ARDX) Stock Could Be 65% Undervalued As Growth Hopes Face Reassessment
Ardelyx (ARDX) is back in focus after recent trading, with the stock closing at $5.67 and showing mixed short term performance, including a decline over the past month and a gain over the past 3 months.
See our latest analysis for Ardelyx.
Looking beyond the latest move, Ardelyx’s share price return is down over the past month but slightly up over the past quarter, while its 1 year total shareholder return is strongly positive. This suggests earlier optimism is being reassessed rather than...